NEWARK, Del, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The Orthobiologics Market is anticipated to thrive at an average CAGR of 3.0% between 2023 and 2033. The market is estimated to reach US$ 8.1 billion by 2033 while it is valued at US$ 6 billion in 2023.
- The precision-based orthobiologics products that provide ease to the patient with pain relief and bone strength are in high demand.
- The use of orthobiologics as a regenerative medicine along with effective treatment is making it the first alternative for the patient with bone injury.
- Rapid growth of the geriatric population, increasing rate of age-related fractures, and increasing implementations of advanced procedures are expected to drive the market growth.
- Severe accidents lead to fatal injuries and bone displacements. Orthobiologics products and regenerative medicines work on these issues and deliver relief to the patient.
- The government investment in regenerative medicines and orthobiologic products is helping the market thrive.
- Advent of advanced bone grafting parameters and medicine with lower side effects are booming the orthobiologics market and making it more future-oriented.
Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-786
Key Points
- The United States market leads the market in terms of market share. It is likely to cross a value of 2.8 billion by 2033. The regional market is expected to thrive at a CAGR of 3.2% between 2023 and 2033.
- The Indian market is leading in terms of CAGR. It thrives at a CAGR of 6.6% during the forecast period. The market is likely to reach US$ 28.7 million by 2033.
- The bone graft substitute is expected to thrive in the product type category as it is an alternative to healing the fracture bones quickly. It is expected to register a CAGR of 3.5% during the forecast period.
- The hospital segment tops the end user tally with a CAGR of 9.1% between 2023 and 2033, due to increasing substitute treatment procedures.
Competitive Landscape
The key players focus on delivering a long range of products that help each patient individually. Furthermore, the advanced regenerative technique is helping a huge population suffering from bone injuries and fractures. The companies also merge, acquire, and partner with other companies to increase the supply chain and distribution channel. The key players in the market include Medtronic, Zimmer Biomet, DePuy Synthes (Johnson & Johnson Services, Inc., Stryker, Anika Therapeutics, Inc, SeaSpine, Bioventus, RTI Surgical, MTF Biologics, Arthrex, Inc, and Smith & Nephew.
Recent Development:
- Collagen Matrix Inc. has introduced a full line of quality collagen and mineral-based pharmaceutical products to support the human body’s natural ability to regenerate. The research is based on tissue learning.
- Bioventus is a company focused on pain treatment products and has launched innovative products for active healing along with therapies for orthopedic care. The company is also engaged in restorative therapies products for fracture treatment and surgical solutions.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-786
Key Segments
By Product Type:
- Bone Growth Stimulators (BGS)
- Non-invasive Electrical BGS
- Invasive Electrical BGS
- Ultrasound BGS
- Viscosupplements
- Single Injection Viscosupplements
- Three Injection Viscosupplements
- Five Injection Viscosupplements
- Bone Graft Substitute
- Allografts
- Synthetics
- Xenografts
- Bone Morphogenetic Protein
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Orthopaedics Clinics
By Region:
- North America
- Latin America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
Browse full Report@ https://www.futuremarketinsights.com/reports/orthobiologics-market
Table of Content
1. Executive Summary | Orthobiologics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
Request for Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-786
Explore FMI’s related ongoing Coverage in Healthcare Market Insights Domain
Biodefense Market Size: The size of the global biodefense market was projected at US$ 16.31 billion in 2023 and is predicted to increase to US$ 32.99 billion by 2033. The expected CAGR for this market's growth throughout the course of the study is 7.3%.
Erythema Treatment Market Share: The market for erythema treatments is anticipated to reach a market size of US$ 184.41 million in 2023 and US$ 315 million in 2033, with a CAGR of 5.5% over that time.
Softgel Capsules Market Trend: The global softgel capsules market is expected to enjoy a valuation of US$ 1.1 Billion by the end of the year 2022, and further expand at a CAGR of 6.0% to reach a valuation of ~US$ 1.9 Billion by the year 2032.
Gastrointestinal Stent Market Growth: By the end of 2022, the market for gastrointestinal stents will be worth US$ 455.44 million. The market is anticipated to grow at a CAGR of 5.5% from 2023 to 2033 and is projected to reach a market value of about US$ 815.34 Million in that year.
Stoma/Ostomy Care Market Demand: By the end of 2022, the market for stoma/ostomy care will be worth US$3.8 billion. The market is anticipated to grow at a CAGR of 4.9% from 2023 to 2033 and is projected to reach a market value of approximately US$ 6.5 billion in that year.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
